Ticker / large cap

REGN

Regeneron Pharmaceuticals, Inc.
3
Contracts
$972.7M
Total Value

Stock Metrics

3.5%
Short % Float
3.9d to cover · Moderate squeeze
93.5%
Inst % Float
10 holders · 2026-06-30
Blackrock Inc.
Top Holder
9.0% of float
97.7M sh
Public Float
10/100
Dilution Score
Low
24+ mo
Cash Runway
Verified regulatory filings & proprietary analysis.

Fleet Intelligence

Dilution Risk
10/100
LOW
Inst: 93.46% · Top: Blackrock Inc.
Squeeze risk: MODERATE

Contracts

DateSourceTitleAwardeeValueScore
2026-08-04usaspending89503126FWA400712RV GLOBAL SOLUTIONS INC.$13K0.0
2017-09-30usaspendingHHSO100201700016CREGENERON PHARMACEUTICALS$693.1M0.2
2017-09-21usaspendingHHSO100201700020CREGENERON PHARMACEUTICALS$279.6M0.1

News Signals

Regeneron Pharmaceuticals, Inc. (REGN) Q2 2026 Earnings Call Transcriptseeking_alpha 20d
REGN — Material Event (8-K)edgar 21d
REGN — Quarterly Report (10-Q)edgar 21d
REGN — Material Event (8-K)edgar 45d